AD, the most prevalent neurodegenerative disease, has been reported to have enhanced genotypic effects of the proteins SPI1 and CD33 encoding proteins at the AD inflammation-related SNP locus as peripheral blood CRP levels increase, and an increased risk of conversion to AD in people with mild cognitive impairment (MCI) (Huang J. et al., 2022). This evidence concerns the gene CRP and Alzheimer disease.